Bayer proposes class settlement for weedkiller cancer claims

Under the proposed agreement, Monsanto would make a series of declining annual payments for up to 21 years, Bayer said, adding that the deal still required court approval. Bayer has spent more than $10 billion settling thousands of cases linked to Roundup since it acquired its producer, the US agrichemical group Monsanto, in 2018. The International Agency for Research on Cancer considers glyphosate, one of Roundup's ingredients, a probable human carcinogen, but Bayer says scientific studies and...